Solomon Kerry D, Sandoval Helga P, Potvin Richard
Carolina Eyecare Physicians, Mt Pleasant, SC, USA.
Science in Vision, Bend, OR, USA.
Clin Ophthalmol. 2020 Jul 10;14:1959-1965. doi: 10.2147/OPTH.S260926. eCollection 2020.
To evaluate the efficacy of a combined steroid/antibiotic/non-steroidal anti-inflammatory drop relative to a regimen of multiple drops after cataract surgery.
Single clinical practice in the USA.
Prospective randomized contralateral eye study.
Subjects presenting for bilateral cataract surgery were enrolled with contralateral eyes randomly assigned to one of the two groups. Test eyes received a combination therapy (prednisolone acetate 1%, gatifloxacin 0.5%, and bromfenac sodium 0.075%) while control eyes received the same medications in separate drops (bromfenac sodium was 0.07%). Subjects were examined 1, 15 and 30 days after surgery. Visual acuities were measured, along with the refraction, intraocular pressure, patient pain and satisfaction, macular thickness and corneal pachymetry. The primary measure of interest was the change in macular thickness from baseline to the 15- and 30-day visits. The frequency and severity of reported ocular adverse events were tabulated for each group and compared.
Thirty-three subjects completed the study. Changes in central macular thickness were similar between groups, with only one control eye exhibiting significant macular edema. No differences in visual acuity, corneal edema, cells or flare were observed between groups. There were eight mild adverse events reported for all eyes of all subjects; the difference in the number of eyes experiencing adverse events was not statistically significantly different between groups (p ≥ 0.05 for all comparisons). While subjective symptoms were similar, all subjects indicated that they preferred the combination drop.
A combination drop showed similar efficacy to multiple drops and was overwhelmingly preferred by subjects.
评估一种类固醇/抗生素/非甾体抗炎药联合滴眼液相对于白内障手术后使用多种滴眼液方案的疗效。
美国的单一临床实践。
前瞻性随机对侧眼研究。
接受双侧白内障手术的受试者入组,对侧眼随机分配至两组之一。试验眼接受联合治疗(1%醋酸泼尼松龙、0.5%加替沙星和0.075%溴芬酸钠),而对照眼接受相同药物的单独滴眼液(溴芬酸钠为0.07%)。术后1天、15天和30天对受试者进行检查。测量视力、验光、眼压、患者疼痛和满意度、黄斑厚度和角膜测厚。主要关注指标是从基线到第15天和第30天随访时黄斑厚度的变化。将每组报告的眼部不良事件的频率和严重程度制成表格并进行比较。
33名受试者完成了研究。两组之间中心黄斑厚度的变化相似,只有一只对照眼出现明显的黄斑水肿。两组之间在视力、角膜水肿、细胞或闪光方面未观察到差异。所有受试者的所有眼睛共报告了8起轻度不良事件;两组之间经历不良事件的眼睛数量差异无统计学意义(所有比较的p≥0.05)。虽然主观症状相似,但所有受试者均表示更喜欢联合滴眼液。
联合滴眼液显示出与多种滴眼液相似的疗效,且受试者压倒性地更喜欢联合滴眼液。